ARTICLE SUMMARY:
With a long history of innovation in heart valve surgery, Milan, Italy-based Sorin Group plans to continue the tradition, staying true to its roots with a pipeline of new products aimed at making complex valve surgeries easier and less invasive. At the same time, the company, which is pursuing a merger with US-based Cyberonics Inc., is also branching into higher-growth/higher-revenue opportunities, including neuromodulation for heart failure and transcatheter mitral valve technologies.
